Results 21 to 30 of about 12,961,080 (334)

Clinical role of apolipoproteins A and B

Кардиоваскулярная терапия и профилактика, 2011
The assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis.
G. A. Chumakova, O. V. Gritsenko, N. G. Veselovskaya, E. V. Vakhromeeva, A. A. Kozarenko   +4 more
doaj   +1 more source

Therapeutic Effect of Hijamah (Cupping Therapy) on Lipid Profiles and Apolipoprotein in Hypercholesterolemic Patients

Jurnal Keperawatan Soedirman, 2022
Hijamah or cupping therapy has a therapeutic effect on cholesterol. However, there is still a lack of studies that investigate the potential effect of cupping in managing apolipoprotein B as a proatherogenic agent and apolipoprotein A-1 as an anti ...
Ratna Pelawati, Wahyudi Widada, Endah Wulandari, Mardiyanti Mardiyanti, Samsiah Samsiah   +4 more
doaj   +1 more source

Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Journal of Clinical Investigation, 1985
Apoproteins B and E both interact with cellular low density lipoprotein (LDL) apolipoprotein B and E (apo B,E)-receptors, and very low density lipoproteins (VLDL) contain both apo B and apo E. Our aim was to study the relative importance of apo B and apo
E. Krul, M. Tikkanen, T. Cole, J. Davie, G. Schonfeld   +4 more
semanticscholar   +1 more source

The correlation of apolipoprotein B, apolipoprotein B/apolipoprotein A-I ratio and lipoprotein(a) with myocardial infarction

Open Medicine, 2008
Abstract Recent evidence shows that apolipoprotein (apo) B, apoB/apoA-I ratio and lipoprotein(a) are better indicators of coronary risk than the conventional lipid profile. The aim of this study was to evaluate the correlation of apoA-I and B, and lipoprotein(a) with myocardial infarction (MI).
M. Gatfosse, Lucia Agoston-Coldea, Teodora Mocan, Dan L. Dumitrascu   +3 more
openaire   +3 more sources

Association of serum lipoproteins and inflammatory parameters derived from the blood test with renal function in COVID-19 outpatients

Brazilian Journal of Pharmaceutical Sciences, 2023
Changes in lipoprotein metabolism are among the main causes of hemodynamic impairment in renal function. COVID-19 is an multisystemic inflammatory disease, aggravating this situation.
Glautemberg de Almeida Viana, Mac Dionys Rodrigues da Costa, Mateus Edson da Silva, Victória da Costa Silva, Arif Ali, Erlânia Alves de Siqueira, Renata de Sousa Alves, Alice Maria Costa Martins, Ramon Róseo Paula Pessoa Bezerra de Menezes, Maria Goretti Rodrigues de Queiroz, Tiago Lima Sampaio   +10 more
doaj   +1 more source

Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particles.

PLoS Pathogens, 2014
Apolipoprotein B (ApoB) and ApoE have been shown to participate in the particle formation and the tissue tropism of hepatitis C virus (HCV), but their precise roles remain uncertain.
Takasuke Fukuhara, Masami Wada, Shota Nakamura, Chikako Ono, Mai Shiokawa, Satomi Yamamoto, Takashi Motomura, Toru Okamoto, Daisuke Okuzaki, Masahiro Yamamoto, Izumu Saito, Takaji Wakita, Kazuhiko Koike, Yoshiharu Matsuura   +13 more
doaj   +1 more source

Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.

Journal of Biological Chemistry, 1991
Recombinant DNA-derived apolipoprotein(a) was used to demonstrate that the apo(a) moiety of lipoprotein(a) (Lp(a)) is responsible for the binding of Lp(a) to other apolipoprotein B-containing lipoproteins (apoB-Lp) including LDL2, a subclass of low density lipoproteins (d = 1.030-1.063 g/ml).
Walter J. McConathy, T F Zioncheck, V N Trieu, R M Lawn   +3 more
openaire   +3 more sources

Interrelationships Between Human Apolipoprotein A-I and Apolipoproteins B-48 and B-100 Kinetics Using Stable Isotopes

Arteriosclerosis, Thrombosis and Vascular Biology, 2004
Objective—Our purpose was to determine the relationship between apolipoprotein (apo) A-I and apoB-48 and apoB-100 metabolism in moderately hypercholesterolemic humans. Methods and Results—The kinetics of apoA-I within high-density lipoprotein (HDL), apoB-
F. Welty, A. Lichtenstein, P. Barrett, Gregory Dolnikowski, E. Schaefer   +4 more
semanticscholar   +1 more source

Comparison of efficacy of intensive versus mild pitavastatin therapy on lipid and inflammation biomarkers in hypertensive patients with dyslipidemia.

PLoS ONE, 2014
ObjectiveIntensive as compared to mild statin therapy has been proven to be superior in improving cardiovascular outcome, whereas the effects of intensive statin therapy on inflammation and lipoprotein biomarkers are not well defined.MethodsThis study ...
Tomohiro Yamasaki, Yoshio Iwashima, Subrina Jesmin, Yuko Ohta, Hiroshi Kusunoki, Shin-ichiro Hayashi, Takeshi Horio, Yuhei Kawano   +7 more
doaj   +1 more source

[5] Apolipoprotein B-48

, 1996
Publisher Summary The methods discussed in this chapter provide fairly simple, sensitive, and reliable means of determining the content of apoB-48 and apoB-100 in Sf>12 lipoproteins, by analytical sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), with subsequent conventional protein staining and gel scanning.
Karpe, F, Hamsten, A, Uffelman, K, Steiner, G   +3 more
openaire   +4 more sources